Over 90 Total Lots Up For Auction at One Location - WA 04/08

Johns Hopkins Medicine expands Raystation treatment planning system

Press releases may be edited for formatting or style | January 04, 2021 Rad Oncology
RaySearch Laboratories AB (publ) announces an expansion of the advanced treatment planning system RayStation®* at the Department of Radiation Oncology and Molecular Sciences at The Sidney Kimmel Comprehensive Cancer Center, in Baltimore, US– an NCI-designated Comprehensive Cancer Center. The expansion includes treatment planning system for photons at the center and several partner sites.

The Johns Hopkins Proton Center at Sibley Memorial Hospital has used RayStation for proton therapy treatment planning since it opened. Now Johns Hopkins Medicine is expanding the use of RayStation to include photon therapy planning for all of its partner centers.

Johns Hopkins Medicine is a leading healthcare system headquartered in Baltimore, Maryland, and treats over 3,000 patients annually using photon therapy. The decision to select RayStation will enable Johns Hopkins to consolidate existing systems and standardize treatment planning throughout the enterprise.

The RayStation installation will provide advanced automation and cutting-edge artificial intelligence features, such as deep learning segmentation and machine learning automated planning. Other key RayStation features will include automated breast planning and fallback planning (automated planning for different modalities with backup plan creation), multi-criteria optimization, deformable registration and adaptive therapy.

The agreement provides for an enterprise configuration for five centers in the Baltimore–Washington D.C. region: The Johns Hopkins Hospital, The Kimmel Cancer Center at Johns Hopkins Bayview, The Kimmel Cancer Center at Green Spring Station, The Sidney Kimmel Comprehensive Cancer Center at Sibley Memorial Hospital, and The Sidney Kimmel Comprehensive Cancer Center at Suburban Hospital.

RayStation represents the next generation of treatment planning systems and is the market leader in proton planning, offering a superior user experience and groundbreaking features and benefits for radiation oncology teams. These include machine learning, automated planning, support for adaptive therapy, multi-criteria optimization, fast and accurate dose computation, robust optimization, and a comprehensive toolbox that enables physicians to efficiently represent the patient anatomy and easily compare and approve plans.

Johan Löf, founder and CEO, RaySearch, says: “We are very pleased to support Johns Hopkins in its expansion of RayStation, which will bring outstanding benefits to patient treatment and workflow efficiency. We look forward to extending our collaboration with Johns Hopkins across the US.”

You Must Be Logged In To Post A Comment